Australian Office

Update on the Australia-Taiwan Health and Biotechnology Partnership


Update on the Australia-Taiwan Health and Biotechnology Partnership

19 July 2023


The Australian Office values our productive partnership with the Ministry of Health and Welfare and the Ministry of Economic Affairs to strengthen health, medicine and biotechnology links between Australia and Taiwan.

Through the Australia-Taiwan Health and Biotechnology Partnership, announced in May 2023, we are deepening cooperation in areas such as clinical trials, biotech innovation and precision medicine.  We are also supporting Australian and Taiwanese companies to explore investment opportunities in digital health innovation and medical research.

A key component of our partnership is participation in the annual BIO Asia-Taiwan and AusBiotech international conferences.  The Australian Office is pleased that over 14 Australian companies will join our Australia Biotech Mission to 2023 BIO Asia-Taiwan: Connecting with the Asian Value Chain: Innovation, Supply, and Investment, including Novotech, George Clinical, Nucleus Network and many others.  Australia’s national pavilion will double in size, highlighting strong interest in market opportunities.

We are also pleased to partner with the Ministry of Economic Affairs’ Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) and the Taiwan Bio Industry Organization (TBIO) to jointly host the Australia-Taiwan Clinical Trials and Biotech Forum.  The Forum will bring together innovative Australian and Taiwanese biotechnology, life science and health companies to exchange information on latest developments, share expertise, and explore concrete opportunities for investment and collaboration in the key areas of clinical trials, biomanufacturing, regenerative medicine, therapeutics, bioresearch and others.

We also continue to deepen cooperation on exchanging public information on clinical trials, R&D, patents and other incentives available to biotech, pharma and medical devices and diagnostics companies in Australia and Taiwan.

Our partnership in health and biotechnology is long-standing and has helped improve the lives of people in Australia and Taiwan in areas such as blood-based disease therapy, influenza vaccines, bionic ear implants, apnea and sleep-related disorder therapy, and many others.

The Australian Office values Taiwan’s contributions in public health, medical care and biotechnology, and we continue to support Taiwan’s meaningful international participation to promote public health security and address other shared challenges.

As long-standing partners with highly complementary economies and strong people-to-people links, Australia and Taiwan are natural partners in these and other areas.

We look forward to further strengthening cooperation to promote the health, wellbeing and prosperity of both our peoples.